search
Back to results

A Web-based Platform to Conduct Trials of mHealth Apps for Hypertension

Primary Purpose

Cardiovascular Risk Factor, Hypertension

Status
Terminated
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
Mobile Health Application
Sponsored by
McMaster University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Cardiovascular Risk Factor focused on measuring mobile health, mhealth

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria

  • age over 18
  • diagnosis of hypertension
  • interested in using an app for hypertension management
  • access to a smartphone with internet connection
  • access to a blood pressure monitoring device (in home or community setting, e.g., pharmacy)

Exclusion Criteria:

  • participant-reported BP within target within the 2 weeks prior to enrolment. Target range for patients with diabetes is systolic BP <130 mm Hg and diastolic BP < 80 mm Hg; for those without diabetes, target range is systolic BP <140 mm Hg and diastolic BP < 90 mm Hg according to Hypertension Canada guidelines
  • emergent hypertensive concerns with systolic BP ≥180 mmHg or diastolic BP ≥120 within the 2 weeks prior to enrolment
  • current use of a mobile app for hypertension management
  • pregnancy
  • not living in Canada
  • unwillingness or inability to give informed consent

Sites / Locations

  • Hamilton Health Sciences
  • McMaster University

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Intervention App Group

Educational Control Group

Arm Description

The intervention group will be instructed to download the chosen hypertension mobile health app (Sphygmo BP) via a link provided on the platform. The hypertension app has blood pressure tracking and monitoring features and they are instructed to use the app. They will also receive a link to the Heart and Stroke foundation website which includes information on hypertension management and measuring blood pressure.

The control will comprise usual care including any anti-hypertensive medication and lifestyle changes, and the link to the Heart and Stroke Foundation website which includes information on hypertension management and measuring blood pressure.

Outcomes

Primary Outcome Measures

Participation completion
Proportion of registered participants who successfully complete the 6-month questionnaire

Secondary Outcome Measures

Change from baseline blood pressure at 6 months
Statistically significant difference in mean change in systolic BP measurements [defined as P<0.05 using a Pearson test] compared to standard ranges from baseline to six months between groups.
Change from baseline self-management adherence at 6 months
Differences in mean change to adherence to hypertension self-care behaviors. This will be scored using the H-SCALE.
Change from baseline healthcare self-efficacy at 6 months
Differences in mean change to healthcare self-efficacy. This will be scored using the frequency distribution and mean of the Health Confidence Score, a 4-item Likert scale.
Change from baseline patient-reported outcomes at 6 months
Descriptive analysis of patient-oriented experiences between groups measured in a 5-point Likert scale questionnaire developed from advisory board themes at 95% confidence interval (CI)
Eligibility rate
The number of patients meeting eligibility criteria in baseline and screening questionnaires.
Consent rate
The proportion of eligible participants consenting to participating in the trial with an electronically signed consent form.
Retention rate
The proportion of withdrawals and drop-outs post-recruitment.
Outcome acceptability
Proportion of questionnaires completed and submitted
Appropriateness of data collection processes
Completeness and accuracy of data in each questionnaire
Recruitment rate
The number of patients successfully recruited to the platform
Change from baseline intervention acceptability at 6 months
Frequency of app usage between control and intervention groups based on answers to questionnaires
Concordance of self-reported blood pressure
Concordance between self-reported blood pressure readings and in-person collected data

Full Information

First Posted
August 19, 2020
Last Updated
April 5, 2022
Sponsor
McMaster University
Collaborators
Canadian Institutes of Health Research (CIHR)
search

1. Study Identification

Unique Protocol Identification Number
NCT04528654
Brief Title
A Web-based Platform to Conduct Trials of mHealth Apps for Hypertension
Official Title
Feasibility of a Web-based Platform to Conduct RCTs of mHealth Apps for CV Risk Factors: Trial My App Hypertension RCT
Study Type
Interventional

2. Study Status

Record Verification Date
April 2022
Overall Recruitment Status
Terminated
Why Stopped
Challenges in recruitment
Study Start Date
April 28, 2021 (Actual)
Primary Completion Date
December 9, 2021 (Actual)
Study Completion Date
December 9, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
McMaster University
Collaborators
Canadian Institutes of Health Research (CIHR)

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Self-management of cardiovascular (CV) risk factors is a recommended form of secondary disease prevention. There are thousands of consumer-facing mobile health (mHealth) applications (apps) intended for tracking, monitoring, and communicating risk factors and health conditions such as hypertension. mHealth apps may be beneficial in improving health status and reducing risk factors. However, the majority of mHealth apps available for consumers have not been scientifically and rigorously evaluated in clinical trials, and due to the fast pace of technological development, those previously evaluated are often outdated by the time trial results are available. Given the rapid pace of change in this field, it is not feasible to rigorously evaluate mHealth apps with current methodologies. McMaster University Health Information Research Unit has developed an innovative research approach using a web-based platform, called Trial My App (TMA), designed to perform efficient, cheap, but high-quality testing of apps relevant to patients with CV risk factors. The overall aim of this pilot study is to test the feasibility of using the web research platform to conduct efficient and rigorous online randomized controlled trials (RCTs) of mHealth apps relevant to patients with CV risk factors. Screening, consent, randomization, and collection of outcomes are completed online using the TMA platform. Recruitment, retention, and completion statistics will be collected in this pilot trial evaluating an mHealth app that targets hypertension. The investigators will partner with clinics in the community to recruit patients to the platform. Study findings will determine if it is feasible to use the relatively simple TMA web-based approach to evaluating the clinical efficacy of mHealth apps for patients with CV risk factors.
Detailed Description
The purpose of this study is to test the feasibility of the newly developed Trial My App platform to conduct an efficient RCT of an mHealth app that targets hypertension, a CV risk factor, without the need for in-person visits. Trial stages, including screening, consent, randomization, and collection of patient-important outcomes, will be performed virtually using the TMA platform. A combination of passive and active recruitment will begin in fall 2020 after ethics approval. A variety of recruitment materials will be distributed by a research assistant to partner newsletters, websites, community practices and primary care or speciality clinic waiting rooms. These materials include videos, paper and online posters/postcards, emails, as well as posts advertising on social media. Social media recruitment will consist of general posts and targeted ads. The primary goal at this stage is to determine whether TMA, the innovative, efficient, web-based methodology, can be used to conduct RCTs evaluating mHealth interventions. The primary feasibility outcome is study completion. Other feasibility outcomes are recruitment rate, eligibility rates, consent rates, retention rates, intervention adherence, and appropriateness of data collection processes. Descriptive analysis will be performed on the dataset using appropriate statistical methods. The secondary objective is to test the clinical efficacy of the chosen mHealth app in reducing BP in patients with sub-optimally controlled hypertension when compared with an educational control group. Efficacy outcomes include clinical assessment changes, self-management adherence, and patient-reported outcomes. This is a pilot, non-blinded, feasibility RCT, comparing use of a hypertension tracking app versus an education control in participants with hypertension that is sub optimally controlled. The investigators will later include a sub-study to validate the blood pressure data inputted into the online platform through in-person blood pressure measurements. Participants will be asked to register on the TMA site and will complete user profile and screening questionnaires and consent for participation in the pilot trial. The participants that meet inclusion criteria will be asked to electronically consent to take part in the pilot trial, and input clinical and patient-important data at 0, 1, 3, and 6 months into the web application.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cardiovascular Risk Factor, Hypertension
Keywords
mobile health, mhealth

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Participants will be randomized using a web-based blocked randomization list and a 1:1 allocation ratio to one of two possible groups, an intervention group or an educational control group.
Masking
Participant
Masking Description
Participants are unblinded. Participants will know if they were assigned to the intervention or control group
Allocation
Randomized
Enrollment
5 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Intervention App Group
Arm Type
Experimental
Arm Description
The intervention group will be instructed to download the chosen hypertension mobile health app (Sphygmo BP) via a link provided on the platform. The hypertension app has blood pressure tracking and monitoring features and they are instructed to use the app. They will also receive a link to the Heart and Stroke foundation website which includes information on hypertension management and measuring blood pressure.
Arm Title
Educational Control Group
Arm Type
No Intervention
Arm Description
The control will comprise usual care including any anti-hypertensive medication and lifestyle changes, and the link to the Heart and Stroke Foundation website which includes information on hypertension management and measuring blood pressure.
Intervention Type
Other
Intervention Name(s)
Mobile Health Application
Other Intervention Name(s)
Sphygmo BP
Intervention Description
The participants will be given instructions to use their smartphone or tablet to download the hypertension tracking app. They will follow the instructions provided within the app and use it to track their blood pressure over the next six months.
Primary Outcome Measure Information:
Title
Participation completion
Description
Proportion of registered participants who successfully complete the 6-month questionnaire
Time Frame
6-months
Secondary Outcome Measure Information:
Title
Change from baseline blood pressure at 6 months
Description
Statistically significant difference in mean change in systolic BP measurements [defined as P<0.05 using a Pearson test] compared to standard ranges from baseline to six months between groups.
Time Frame
Baseline, 6-months
Title
Change from baseline self-management adherence at 6 months
Description
Differences in mean change to adherence to hypertension self-care behaviors. This will be scored using the H-SCALE.
Time Frame
Baseline, 6-months
Title
Change from baseline healthcare self-efficacy at 6 months
Description
Differences in mean change to healthcare self-efficacy. This will be scored using the frequency distribution and mean of the Health Confidence Score, a 4-item Likert scale.
Time Frame
Baseline, 6-months
Title
Change from baseline patient-reported outcomes at 6 months
Description
Descriptive analysis of patient-oriented experiences between groups measured in a 5-point Likert scale questionnaire developed from advisory board themes at 95% confidence interval (CI)
Time Frame
Baseline, 6-months
Title
Eligibility rate
Description
The number of patients meeting eligibility criteria in baseline and screening questionnaires.
Time Frame
Baseline
Title
Consent rate
Description
The proportion of eligible participants consenting to participating in the trial with an electronically signed consent form.
Time Frame
Baseline
Title
Retention rate
Description
The proportion of withdrawals and drop-outs post-recruitment.
Time Frame
6-months
Title
Outcome acceptability
Description
Proportion of questionnaires completed and submitted
Time Frame
6-months
Title
Appropriateness of data collection processes
Description
Completeness and accuracy of data in each questionnaire
Time Frame
6-months
Title
Recruitment rate
Description
The number of patients successfully recruited to the platform
Time Frame
Baseline
Title
Change from baseline intervention acceptability at 6 months
Description
Frequency of app usage between control and intervention groups based on answers to questionnaires
Time Frame
Baseline, 6-months
Title
Concordance of self-reported blood pressure
Description
Concordance between self-reported blood pressure readings and in-person collected data
Time Frame
6-months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria age over 18 diagnosis of hypertension interested in using an app for hypertension management access to a smartphone with internet connection access to a blood pressure monitoring device (in home or community setting, e.g., pharmacy) Exclusion Criteria: participant-reported BP within target within the 2 weeks prior to enrolment. Target range for patients with diabetes is systolic BP <130 mm Hg and diastolic BP < 80 mm Hg; for those without diabetes, target range is systolic BP <140 mm Hg and diastolic BP < 90 mm Hg according to Hypertension Canada guidelines emergent hypertensive concerns with systolic BP ≥180 mmHg or diastolic BP ≥120 within the 2 weeks prior to enrolment current use of a mobile app for hypertension management pregnancy not living in Canada unwillingness or inability to give informed consent
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Cynthia Lokker, PhD
Organizational Affiliation
McMaster University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hamilton Health Sciences
City
Hamilton
State/Province
Ontario
ZIP/Postal Code
L8L2X2
Country
Canada
Facility Name
McMaster University
City
Hamilton
State/Province
Ontario
ZIP/Postal Code
L8S4L8
Country
Canada

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
There is no plan to make individual participant data (IPD) available to other researchers.
Citations:
PubMed Identifier
33522978
Citation
Lokker C, Jezrawi R, Gabizon I, Varughese J, Brown M, Trottier D, Alvarez E, Schwalm JD, McGillion M, Ma J, Bhagirath V. Feasibility of a Web-Based Platform (Trial My App) to Efficiently Conduct Randomized Controlled Trials of mHealth Apps For Patients With Cardiovascular Risk Factors: Protocol For Evaluating an mHealth App for Hypertension. JMIR Res Protoc. 2021 Feb 1;10(2):e26155. doi: 10.2196/26155.
Results Reference
derived

Learn more about this trial

A Web-based Platform to Conduct Trials of mHealth Apps for Hypertension

We'll reach out to this number within 24 hrs